Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
2021 · Clinical Lymphoma Myeloma & Leukemia · 18 citations
https://doi.org/10.1016/j.clml.2021.01.013